← Open Payments lookup

LISA LAMBERTI: Open Payments

NPI 1992794192 · MONTCLAIR, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,709 in 102 payments from 18 companies in 2025. Trend: 2023 $1,634 · 2024 $1,796 · 2025 $1,709

Food & beverage: $1,709
CompanyPaymentsAmount
ABBVIE INC.31$437
Janssen Biotech, Inc.17$305
Aimmune Therapeutics, Inc.13$296
Gilead Sciences, Inc.7$112
Celltrion USA Inc.6$112
Takeda Pharmaceuticals U.S.A., Inc.4$70
Madrigal Pharmaceuticals4$61
Intercept Pharmaceuticals, Inc.3$53
PFIZER INC.3$50
Biocon Biologics Inc2$39

Products named: TREMFYA, ZENPEP, SKYRIZI, VEGZELMA, RINVOQ, REZDIFFRA, VIBERZI, MAVYRET.

Industry payments across NJ — which companies pay providers there.